Un estudio estadounidense difundido el martes revela que la hidroxicloroquina no mostró ningún beneficio contra la enfermedad. El medicamento contra la malaria había sido ampliamente promocionado como una posible cura para la COVID-19, pero de hecho se asoció con más muertes. (Fuente: AFP)
:quality(75)/cdn.jwplayer.com/v2/media/VYBtNakX/poster.jpg)
:quality(75)/dvgnzpfv30f28.cloudfront.net/04-23-2020/t_519a78c7aaf84dc58023eef089284bba_name_hd1.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/p9PZmF6o/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FFTXQF2GENAWHKRPAGAYPXAMQA.png)
:quality(75)/cdn.jwplayer.com/v2/media/ktXEiX31/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/VYBtNakX/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/o1KPg1hs/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/TvvzxktF/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/rtpKhHdf/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/jLDF76V0/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/M7zaFLzu/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Z0QzjVsW/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/aXFgbnY1/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/p9PZmF6o/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/ktXEiX31/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/M4tmnvJD/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/UCjyX8ro/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FFTXQF2GENAWHKRPAGAYPXAMQA.png)
:quality(75)/cdn.jwplayer.com/v2/media/e3PteUbd/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/S3FWV3XJHFFNJK5E7ONZMBK3T4.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/CUNPAOro/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/koNs9MA2/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/6bLTGi5d/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/KgeU8b6Q/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/a6mwPQ4X/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/X3PAJUVAAFHRXHUYV5TON7UAAY.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/wXUo9jVU/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/nu9nKgwG/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/GCHGHNUMHVAIDBFA2VHOVRIAMY.png)
:quality(75)/cdn.jwplayer.com/v2/media/c0S03whF/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/azLadx4o/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FQ5XSTUGQ5DI3DYDC3MUSLQL6A.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/9a1H4G0a/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/yOEdb2ys/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/JDVYxTbd/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/LIy1dI2W/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Xv8iJGpA/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/JW2JBE7IBZEY5NR2VH4KVTPGZ4.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/42WZKDIDGVA6VKQDF75376W2CA.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ENCJ6JEIFZHT5E6UXK3KZ5RCUU.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/UZ27WLDNBFBCPCMLG42DQCNJYA.png)